Cervical cancer is due to a persistent infection with a group of viruses known as high-risk Human Papillomaviruses (hrHPV). Viral DNA can be easily detected in a cervical sample by a procedure called 'HPV testing', which can be used as a relevant screening test. A pilot screening program called START-HPV has been set up in the Ardennes, a French administrative area localized in the North of France, with HPV testing as a primary screening test.This observational study aimed to evaluate hrHPV genotypes repartition in the population who participate in the START-HPV screening program. This study will allow a better knowledge of hrHPV infection epidemiology in a screened population.

Inclusion Criteria:

• to live in the Ardennes department (France)
• affiliation to a health insurance organism
• 31 to 65 years old

Exclusion Criteria:

• current follow-up for cervical cytological abnormalities
• history of hysterectomy
• reimbursement for a Pap smear in the last 3 years

Women who participate in START-HPV pilot screening program and tested positive for high-risk HPV